Skip to content

The effects of epidural steroid injection

Comparison of the effects of two different methods of epidural steroid injection after recurrent lubmar disc herniation

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT138903084047N1
Enrollment
30
Registered
2010-11-12
Start date
2010-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent lumbar discopathy. nerve root and plexus

Interventions

Intervention 1: Injection of 40 mg methylprednisolone in epidural sapce of spinal column via caudal method. Intervention 2: Injection of 40 mg methylprednisolone in epidural sapce of spinal column via
Treatment - Other
Injection of 40 mg methylprednisolone in epidural sapce of spinal column via caudal method
Injection of 40 mg methylprednisolone in epidural sapce of spinal column via transforaminal method

Sponsors

Kerman Neuroscience Research Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: recurrent disc herniation who do not respond to conventional treatment, radicular pain is greater than lumbar pain, 6 weeks past from pain onset Exclusion criteria: severe extruded intervertebral disc, progressive neurological deficit, history of steroid injection for lumbar or radicular pain, financial or complaint gain, history of coagulopathy or allergy to anesthetic agent or corticosteroid, pregnancy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of pain. Timepoint: 1, 2 & 6 months after the intervention. Method of measurement: numerical pain score.;Walking tolerance. Timepoint: 1, 2 & 6 months after the intervention. Method of measurement: meter.;Standing tolerance. Timepoint: 1, 2 & 6 months after the intervention. Method of measurement: minute.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeid Karamouzian

Kerman Neuroscience Research Center

karamouzian@gmail.com+98 913 341 5316

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026